2021 Sustainability Report of Sai Life Sciences highlights the momentum gained in its Sustainability choices
Sai Life Sciences today announced the release of its 2021 Sustainability Report.
Developed as per the Global Reporting Initiative (GRI) standards, the report highlights the momentum gained by the company in its Sustainability choices and elaborates on how the pandemic has helped the company galvanise change in the organization, positively impacting its various stakeholders.
The full report can be accessed here. Making the announcement, Krishna Kanumuri, CEO & Managing Director said, “In a year that was significantly impacted by the Covid-19 pandemic, we made tremendous progress in advancing our Sustainability agenda. The 2021 report describes the momentum we have gained in because of the renewed thrust we have placed in this important sphere.”
The 2021 Report underscores how the company’s organizational transformation initiative, SaiNxt helped it gain momentum on its sustainability choices while highlighting its progress on issues that are critical for its business and stakeholders.
. Exceeded target on the shift towards renewable energy sources
. Implemented 10 projects in energy management with cumulative savings of 1.3 million KWh/annum
. Strengthened adoption of green chemistry principles in process development
. Conducted multiple programmes engaging shop floor teams towards operational excellence - KPI monitoring, team effectiveness, Kaizens, rewards & recognition
. Received 5-Star rating for Excellence in EHS Practices at the Confederation of Indian Industry (CII) South awards 2019 & 2020
. Manufacturing site recognised as ‘Excellent Energy Efficient Unit’ at CII’s National Energy Management Awards in 2021and 2020 .
. Won two awards at the prestigious 2021 Association for Talent Development – Excellence in Practice (ATD-EIP) awards.
The report also extensively deals with the impact of the Covid-19 pandemic and how the company dealt with the challenges to ensure employee health & safety and business continuity, while supporting the community in dealing with the pandemic.
SreeKrishna Chopperla, Sr Vice President and Head of HSE said, “The paramount challenge of 2021 was dealing with COVID 19 pandemic. As we improved our performance on various fronts, we also ensured that all our stakeholders got the necessary support and confidence in dealing with the pandemic. As we move forward, we are furthering our commitment to Sustainability with proactive measures such as becoming a signatory to UNGC, aligning to SA 8000 standards, ISO 50001 management standards and redefining our goals post FY 22.”
Recent highlights that exemplify and validate the company’s progress on Sustainability:
. Became a signatory to the United Nations Global Compact (UNGC)
. Won GSK’s Environmental Sustainability Supplier award 2021 in the ‘Primary . Manufacturing’ category
. Achieved EcoVadis Silver for Sustainability
. Won Gold Award at Brandon Hall Group Excellence Awards under the “Best Advance . in Learning Technology Implementation” category.
. Honoured with the Golden Peacock National Training Award 2021 in the pharmaceutical category.
Sponsored Content How healthcare trends inform dosage formsCapsules encompass one of the most popular solid oral dosage forms for pharmaceutical products, with the global empty capsule market predicted to rise to USD $3.7 billion by 2026. The growth in the capsule market can be partly attributed to the many op...
Sponsored Content 2023 Pharma Trend Outlook: Innovation, Resilience, and Pharma 4.0Download our 2023 Pharma Trends Outlook report to discover the trends set to shape the pharmaceutical landscape in the new year, with expert opinions and insight from across the pharmaceutical value chain.
Sponsored Content CPHI Podcast Series: Key Considerations in Selecting the Right CMO PartnerIn this month's episode we hear from Jayna Blake, Senior Project Manager for Technical Programs at Baxter BioPharma Solutions, on key considerations for successful CMO selection.
Sponsored Content PharmaNutra announces new technology to combat iron deficiencyThis oral solution allows for high iron absorption while minimising digestive issues
Sponsored Content Size doesn’t matter: How smaller deals are shaping healthcare M&ASeveral mega-deals have made a splash in the pharma and life sciences industries over recent years – from AstraZeneca’s acquisition of Alexion for $39 billion to Gilead Sciences’ $21 billion purchase of Immunomedics. With am...
Sponsored Content Rise in home-based healthcare shaping pharma packaging and drug deliveryThe pharma packaging and drug delivery industry has long been synonymous with rapid innovation. As medicine advances and patient needs change, so too should drug packaging and devices. This has been particularly evident during the pandem...
Sponsored Content Biologics earmarked as opportunity in pharma packaging and drug deliveryThe pharma packaging and drug delivery industry has gone through many evolutions, most notably to meet the challenges posed by the COVID-19 pandemic over the last two years. Disruptions to global supply chains posed a major issue, combined with a sharp...
Sponsored Content Sustainability and digital adoption among trends shaping pharma packaging and drug deliveryThe pharma packaging and drug device industry is constantly evolving to optimise drug delivery, keep up with medical advances and ensure regulatory compliance. Trends like sustainability, cost-efficiency and digitisation continue to shape the sector, a...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
Generate high-quality, engaged leads for your business, all year round
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
Your company’s profile boosted at all participating CPHI events
An easy-to-use platform with a detailed dashboard showing your leads and performance